Monkey Guanosine 5-triphosphate Cyclohydrolase1 ELISA Kit | GCH1 elisa kit

Monkey Guanosine 5-triphosphate Cyclohydrolase1 ELISA Kit

Cat. Num. AAA738729

• Gene Names: GCH1; GCH; DYT5; DYT14; DYT5a; GTPCH1; HPABH4B; GTP-CH-1
• Reactivity: Monkey
• Synonyms: Guanosine 5-triphosphate Cyclohydrolase1; Monkey Guanosine 5-triphosphate Cyclohydrolase1 ELISA Kit; GCH1 elisa kit

• Reactivity: Monkey

• Samples: Serum, plasma, Cell Culture Supernatants, body fluid and tissue homogenate
• Assay Type: Sandwich
• Detection Range: 50-1000ng/mL
• Sensitivity: 1.0ng/mL
• Intended Uses: This GCH1 ELISA kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of Monkey GCH1. This ELISA kit for research use only, not for therapeutic applications!
• Preparation and Storage: Store all reagents at 2-8 degree C.

Typical Testing Data/Standard Curve (for reference only)

Related Product Information for GCH1 elisa kit

Principle of the Assay: GCH1 ELISA kit applies the competitive enzyme immunoassay technique utilizing a monoclonal anti-GCH1 antibody and an GCH1-HRP conjugate. The assay sample and buffer are incubated together with GCH1-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the GCH1 concentration since GCH1 from samples and GCH1-HRP conjugate compete for the anti-GCH1 antibody binding site. Since the number of sites is limited, as more sites are occupied by GCH1 from the sample, fewer sites are left to bind GCH1-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The GCH1 concentration in each sample is interpolated from this standard curve.

Product Categories/Family for GCH1 elisa kit

Neurobiology

NCBI and Uniprot Product Information

• NCBI GI #: 66932972
• NCBI GeneID: 2643
• NCBI Accession #: NP_001019242.1
• NCBI GenBank Nucleotide #: NM_001024071.1
• Molecular Weight: 25,775 Da
• NCBI Official Full Name: GTP cyclohydrolase 1 isoform 3
• NCBI Official Synonym Full Names: GTP cyclohydrolase 1
• NCBI Official Symbol: GCH1
• NCBI Official Synonym Symbols: GCH; DYT5; DYT14; DYT5a; GTPCH1; HPABH4B; GTP-CH-1
• NCBI Protein Information: GTP cyclohydrolase 1; GTP-CH-I; dystonia 14; GTP cyclohydrolase I; guanosine 5'-triphosphate cyclohydrolase I
• UniProt Protein Name: GTP cyclohydrolase 1
• Protein Family: GTP cyclohydrolase
• UniProt Gene Name: GCH1
• UniProt Synonym Gene Names: DYT5; GCH; GTP-CH-I
• UniProt Entry Name: GCH1_HUMAN

NCBI Description

This gene encodes a member of the GTP cyclohydrolase family. The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. Mutations in this gene are associated with malignant hyperphenylalaninemia and dopa-responsive dystonia. Several alternatively spliced transcript variants encoding different isoforms have been described; however, not all variants give rise to a functional enzyme. [provided by RefSeq, Jul 2008]

Uniprot Description

GCH1: Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function of the enzymatically inactive isoforms remains unknown. Defects in GCH1 are the cause of GTP cyclohydrolase 1 deficiency (GCH1D); also known as atypical severe phenylketonuria due to GTP cyclohydrolase I deficiency;. GCH1D is one of the causes of malignant hyperphenylalaninemia due to tetrahydrobiopterin deficiency. It is also responsible for defective neurotransmission due to depletion of the neurotransmitters dopamine and serotonin. The principal symptoms include: psychomotor retardation, tonicity disorders, convulsions, drowsiness, irritability, abnormal movements, hyperthermia, hypersalivation, and difficulty swallowing. Some patients may present a phenotype of intermediate severity between severe hyperphenylalaninemia and mild dystonia type 5 (dystonia- parkinsonism with diurnal fluctuation). In this intermediate phenotype, there is marked motor delay, but no mental retardation and only minimal, if any, hyperphenylalaninemia. Defects in GCH1 are the cause of dystonia type 5 (DYT5); also known as progressive dystonia with diurnal fluctuation, autosomal dominant Segawa syndrome or dystonia- parkinsonism with diurnal fluctuation. DYT5 is a DOPA-responsive dystonia. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT5 typically presents in childhood with walking problems due to dystonia of the lower limbs and worsening of the dystonia towards the evening. It is characterized by postural and motor disturbances showing marked diurnal fluctuation. Torsion of the trunk is unusual. Symptoms are alleviated after sleep and aggravated by fatigue and excercise. There is a favorable response to L-DOPA without side effects. Belongs to the GTP cyclohydrolase I family. 4 isoforms of the human protein are produced by alternative splicing.

Protein type: Cofactor and Vitamin Metabolism - folate biosynthesis; EC 3.5.4.16; Hydrolase

Chromosomal Location of Human Ortholog: 14q22.1-q22.2

Cellular Component: nucleoplasm; nuclear membrane; protein complex; cytoplasm; cytoplasmic vesicle; nucleus; cytosol

Molecular Function: GTP cyclohydrolase I activity; protein binding; protein homodimerization activity; GTP binding; zinc ion binding; GTP-dependent protein binding; calcium ion binding; coenzyme binding

Biological Process: tetrahydrobiopterin biosynthetic process; regulation of lung blood pressure; metabolic process; protein heterooligomerization; positive regulation of nitric-oxide synthase activity; response to lipopolysaccharide; response to pain; dopamine biosynthetic process; pteridine and derivative biosynthetic process; nitric oxide metabolic process; vasodilation; neuromuscular process controlling posture; tetrahydrofolate biosynthetic process; regulation of blood pressure; negative regulation of blood pressure; regulation of nitric-oxide synthase activity; nitric oxide biosynthetic process; protein homooligomerization

Disease: Hyperphenylalaninemia, Bh4-deficient, B; Dystonia, Dopa-responsive